BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19778630)

  • 21. Do biologically relevant compounds have more chance to be drugs?
    Kong DX; Ren W; Lü W; Zhang HY
    J Chem Inf Model; 2009 Oct; 49(10):2376-81. PubMed ID: 19852515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial toxins--an overview.
    Lahiri SS
    J Nat Toxins; 2000 Nov; 9(4):381-408. PubMed ID: 11126516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of natural products as a source of new antibiotics.
    Luzhetskyy A; Pelzer S; Bechthold A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness data on biologics needed.
    Sheridan C; Katsnelson A
    Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
    [No Abstract]   [Full Text] [Related]  

  • 25. The biosynthetic potential of myxobacteria and their impact in drug discovery.
    Wenzel SC; Müller R
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):220-30. PubMed ID: 19333867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New therapy option for problem patients. What is the value of "biologics" in psoriasis?].
    Boehncke WH
    MMW Fortschr Med; 2004 Nov; 146(46):45. PubMed ID: 15600044
    [No Abstract]   [Full Text] [Related]  

  • 27. The discovery of antibacterial agents using diversity-oriented synthesis.
    Galloway WR; Bender A; Welch M; Spring DR
    Chem Commun (Camb); 2009 May; (18):2446-62. PubMed ID: 19532856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional molecules from natural sources: organized by the Royal Society of Chemistry Biotechnology Group, Magdalen College, Oxford, UK, 6-8 July 2009.
    Wrigley SK
    J Antibiot (Tokyo); 2009 Nov; 62(11):649-50. PubMed ID: 19798120
    [No Abstract]   [Full Text] [Related]  

  • 31. An audience with...Peter Kiener.
    Kiener P
    Nat Rev Drug Discov; 2009 Jul; 8(7):532. PubMed ID: 19568280
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of natural products on developing new anti-cancer agents.
    Cragg GM; Grothaus PG; Newman DJ
    Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222
    [No Abstract]   [Full Text] [Related]  

  • 33. Changing role of formulation in biologics drug development.
    Saylor T
    Drug Discov Today; 2014 Aug; 19(8):1031-2. PubMed ID: 24815923
    [No Abstract]   [Full Text] [Related]  

  • 34. Insects and their chemical weaponry: new potential for drug discovery.
    Dossey AT
    Nat Prod Rep; 2010 Jan; 27(12):1737-57. PubMed ID: 20957283
    [No Abstract]   [Full Text] [Related]  

  • 35. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
    Patwardhan B; Mashelkar RA
    Drug Discov Today; 2009 Aug; 14(15-16):804-11. PubMed ID: 19477288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are we seeing a resurgence in the use of natural products for new drug discovery?
    Li F; Wang Y; Li D; Chen Y; Dou QP
    Expert Opin Drug Discov; 2019 May; 14(5):417-420. PubMed ID: 30810395
    [No Abstract]   [Full Text] [Related]  

  • 37. Biologics as cancer treatment modalities.
    Smalley RV
    Wis Med J; 1987 Nov; 86(11):19-21. PubMed ID: 2447705
    [No Abstract]   [Full Text] [Related]  

  • 38. Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission.
    van Eden W; Lisse J; Prakken B; Albani S
    Drug Discov Today; 2010 Jan; 15(1-2):71-7. PubMed ID: 19162218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products as drug leads: an old process or the new hope for drug discovery?
    Kingston DG; Newman DJ
    IDrugs; 2005 Dec; 8(12):990-2. PubMed ID: 16320131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The year's new drugs & biologics - 2008.
    Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
    Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.